Accell open a regional clinical office in Riga, Latvia to meet the demand for regulatory and pharmacovigilance services in the European Union. An Latvian office facilitates regulatory reporting in the European Union.
Located near Charlottesville, VA, with easy access to Washington, D.C., Northern Virginia and Maryland, our Virginia office serves as a strong anchor for the outreach to East Coast biopharmaceutical industry.
To provide regulatory services, Accell establishes a regional clinical office in Kiev, Ukraine. Our clients gain reliable access to a largely untapped patient population with the Accell’s rigorous quality management practices applied.
Accell begins working in Europe on the first project with breast cancer patients, covering Sweden, Germany, France, Baltic countries, Russia and Ukraine.
Accell is established as a clinical CRO providing Phase I – IV clinical study management services. The company serves as a reliable partner in completing clinical studies on time, and the first three Phase II oncology studies are initiated.